nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—PPARD—Pyruvate metabolism and Citric Acid (TCA) cycle—SDHB—adrenal gland cancer	0.0805	0.0816	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors—NR5A1—adrenal gland cancer	0.0737	0.0746	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.0583	0.059	CbGpPWpGaD
Treprostinil—PPARD—Pyruvate metabolism and Citric Acid (TCA) cycle—SDHD—adrenal gland cancer	0.0519	0.0526	CbGpPWpGaD
Treprostinil—PTGIR—Prostacyclin signalling through prostacyclin receptor—GNAS—adrenal gland cancer	0.0415	0.0421	CbGpPWpGaD
Treprostinil—PPARD—The citric acid (TCA) cycle and respiratory electron transport—SDHB—adrenal gland cancer	0.0312	0.0316	CbGpPWpGaD
Treprostinil—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.0281	0.0284	CbGpPWpGaD
Treprostinil—PTGIR—Endothelin Pathways—GNAS—adrenal gland cancer	0.0267	0.027	CbGpPWpGaD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—PRKACA—adrenal gland cancer	0.0216	0.0219	CbGpPWpGaD
Treprostinil—PPARD—The citric acid (TCA) cycle and respiratory electron transport—SDHD—adrenal gland cancer	0.0201	0.0204	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—SPRY2—adrenal gland cancer	0.0165	0.0167	CbGpPWpGaD
Treprostinil—PTGIR—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0159	0.0161	CbGpPWpGaD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.0155	0.0157	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0154	0.0156	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0142	0.0144	CbGpPWpGaD
Treprostinil—PTGIR—Platelet homeostasis—GNAS—adrenal gland cancer	0.0134	0.0136	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.0128	0.0129	CbGpPWpGaD
Treprostinil—Nadolol—ABCB1—adrenal gland cancer	0.0125	1	CrCbGaD
Treprostinil—P2RY12—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0118	0.0119	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0108	0.011	CbGpPWpGaD
Treprostinil—PPARD—Presenilin action in Notch and Wnt signaling—CTNNB1—adrenal gland cancer	0.0108	0.0109	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.0101	0.0102	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00927	0.00938	CbGpPWpGaD
Treprostinil—PTGIR—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00926	0.00938	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00925	0.00937	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00852	0.00862	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00825	0.00835	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00759	0.00769	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00705	0.00714	CbGpPWpGaD
Treprostinil—PTGIR—Thromboxane A2 receptor signaling—EGFR—adrenal gland cancer	0.00666	0.00674	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00665	0.00673	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00663	0.00672	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00649	0.00657	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—RB1—adrenal gland cancer	0.0064	0.00648	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00639	0.00647	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—TSHR—adrenal gland cancer	0.00628	0.00636	CbGpPWpGaD
Treprostinil—PTGIR—G alpha (s) signalling events—POMC—adrenal gland cancer	0.00624	0.00631	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00612	0.0062	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00605	0.00612	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00604	0.00611	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00603	0.00611	CbGpPWpGaD
Treprostinil—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00593	0.006	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—TSHR—adrenal gland cancer	0.00578	0.00585	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.00578	0.00585	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—CTNNB1—adrenal gland cancer	0.00571	0.00579	CbGpPWpGaD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00565	0.00572	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00556	0.00563	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00508	0.00515	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—NR5A1—adrenal gland cancer	0.00484	0.00491	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SPARC—adrenal gland cancer	0.00478	0.00484	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SDHB—adrenal gland cancer	0.00471	0.00477	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—CTNNB1—adrenal gland cancer	0.00471	0.00476	CbGpPWpGaD
Treprostinil—PPARD—Ectoderm Differentiation—CTNNB1—adrenal gland cancer	0.00449	0.00454	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SPARC—adrenal gland cancer	0.0044	0.00445	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00406	0.00411	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PRKACA—adrenal gland cancer	0.00403	0.00408	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00398	0.00403	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—adrenal gland cancer	0.0038	0.00385	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PRKACA—adrenal gland cancer	0.00371	0.00376	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00371	0.00376	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00367	0.00371	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—GNAS—adrenal gland cancer	0.00365	0.0037	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00362	0.00366	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GNRHR—adrenal gland cancer	0.00357	0.00361	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00355	0.00359	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—CDC42—adrenal gland cancer	0.00342	0.00346	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—GNAS—adrenal gland cancer	0.00336	0.00341	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00333	0.00337	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00332	0.00336	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IGF2—adrenal gland cancer	0.0033	0.00334	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GNRHR—adrenal gland cancer	0.00328	0.00332	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—GNAS—adrenal gland cancer	0.00327	0.00331	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00327	0.00331	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00323	0.00327	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—TSHR—adrenal gland cancer	0.00322	0.00326	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—CDC42—adrenal gland cancer	0.00315	0.00319	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00312	0.00316	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00305	0.00309	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—RRM1—adrenal gland cancer	0.00304	0.00307	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SDHD—adrenal gland cancer	0.00304	0.00307	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IGF2—adrenal gland cancer	0.00303	0.00307	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—GNAS—adrenal gland cancer	0.00301	0.00304	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00297	0.00301	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—TSHR—adrenal gland cancer	0.00297	0.003	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MED12—adrenal gland cancer	0.00291	0.00295	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00287	0.0029	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MEN1—adrenal gland cancer	0.00278	0.00282	CbGpPWpGaD
Treprostinil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00246	0.00249	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—POMC—adrenal gland cancer	0.00246	0.00249	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00231	0.00234	CbGpPWpGaD
Treprostinil—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00227	0.0023	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—POMC—adrenal gland cancer	0.00226	0.00229	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MED12—adrenal gland cancer	0.00226	0.00229	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00216	0.00219	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GNRH1—adrenal gland cancer	0.00214	0.00216	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00213	0.00216	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00206	0.00209	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00202	0.00205	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00199	0.00202	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00199	0.00201	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GNRH1—adrenal gland cancer	0.00197	0.00199	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CDC42—adrenal gland cancer	0.00196	0.00199	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SPRY2—adrenal gland cancer	0.00195	0.00198	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TSHR—adrenal gland cancer	0.0019	0.00193	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0019	0.00192	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—GNAS—adrenal gland cancer	0.00188	0.0019	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CDC42—adrenal gland cancer	0.00181	0.00183	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SPRY2—adrenal gland cancer	0.0018	0.00182	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MEN1—adrenal gland cancer	0.00179	0.00181	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TSHR—adrenal gland cancer	0.00175	0.00177	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GNAS—adrenal gland cancer	0.00173	0.00175	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PRKACA—adrenal gland cancer	0.00165	0.00167	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MEN1—adrenal gland cancer	0.00165	0.00167	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00161	0.00163	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—POMC—adrenal gland cancer	0.00139	0.00141	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKACA—adrenal gland cancer	0.00137	0.00138	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GNAS—adrenal gland cancer	0.00134	0.00136	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ABCB1—adrenal gland cancer	0.00131	0.00133	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—POMC—adrenal gland cancer	0.00128	0.0013	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—POMC—adrenal gland cancer	0.00126	0.00128	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKACA—adrenal gland cancer	0.00126	0.00127	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—POMC—adrenal gland cancer	0.00116	0.00118	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CDC42—adrenal gland cancer	0.00116	0.00117	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF2—adrenal gland cancer	0.00112	0.00113	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GNAS—adrenal gland cancer	0.00111	0.00112	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1R—adrenal gland cancer	0.00108	0.00109	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CDC42—adrenal gland cancer	0.00107	0.00108	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.00106	0.00107	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—adrenal gland cancer	0.00104	0.00106	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF2—adrenal gland cancer	0.00103	0.00104	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00102	0.00104	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GNAS—adrenal gland cancer	0.00102	0.00103	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1R—adrenal gland cancer	0.000994	0.00101	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—adrenal gland cancer	0.000961	0.000973	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000947	0.000959	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TERT—adrenal gland cancer	0.00093	0.000942	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—POMC—adrenal gland cancer	0.000901	0.000913	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TERT—adrenal gland cancer	0.000856	0.000867	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BAD—adrenal gland cancer	0.000809	0.000819	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—POMC—adrenal gland cancer	0.000746	0.000755	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000746	0.000755	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BAD—adrenal gland cancer	0.000745	0.000754	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BRAF—adrenal gland cancer	0.000736	0.000746	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—adrenal gland cancer	0.000719	0.000728	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—EGFR—adrenal gland cancer	0.000714	0.000723	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—POMC—adrenal gland cancer	0.000686	0.000695	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BRAF—adrenal gland cancer	0.000678	0.000686	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EGFR—adrenal gland cancer	0.000657	0.000665	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000611	0.000618	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000611	0.000618	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000532	0.000539	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00049	0.000496	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000455	0.000461	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EGFR—adrenal gland cancer	0.000422	0.000427	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000407	0.000412	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EGFR—adrenal gland cancer	0.000388	0.000393	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—adrenal gland cancer	0.000354	0.000359	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000332	0.000336	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—adrenal gland cancer	0.000326	0.00033	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000325	0.000329	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000269	0.000273	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000264	0.000267	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000181	0.000184	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.000145	0.000146	CbGpPWpGaD
